M
Michelle N. Strecker
Researcher at University of California, San Francisco
Publications - 6
Citations - 1210
Michelle N. Strecker is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Genetic counseling & Public health. The author has an hindex of 5, co-authored 6 publications receiving 1002 citations.
Papers
More filters
Journal ArticleDOI
A new definition of Genetic Counseling: National Society of Genetic Counselors' Task Force report.
Robert G. Resta,Barbara B. Biesecker,Robin L. Bennett,Sandra Blum,Susan E. Hahn,Michelle N. Strecker,Janet L. Williams +6 more
TL;DR: The Genetic Counseling Definition Task Force of the National Society of Genetic Counselors developed the following definition of genetic counseling that was approved by the NSGC Board of Directors: genetic counseling is the process of helping people understand and adapt to the medical, psychological and familial implications of genetic contributions to disease.
Journal ArticleDOI
Genetic counseling and testing for Alzheimer disease: Joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors
Jill Goldman,Susan E. Hahn,Jennifer Williamson Catania,Susan Larusse-Eckert,Melissa Barber Butson,Malia Rumbaugh,Michelle N. Strecker,J. Scott Roberts,Wylie Burke,Richard Mayeux,Thomas D. Bird +10 more
TL;DR: This practice guideline provides clinicians with a framework for assessing their patients' genetic risk for Alzheimer disease, identifying which individuals may benefit from genetic testing, and providing the key elements of genetic counseling for AD.
Journal ArticleDOI
Comprehensive genetic analysis of pregnancy loss by chromosomal microarrays: outcomes, benefits, and challenges.
Trilochan Sahoo,Natasa Dzidic,Michelle N. Strecker,Sara Commander,Mary K. Travis,Charles Doherty,R. Weslie Tyson,Arturo E. Mendoza,Mary D. Stephenson,Craig A. Dise,Carlos W. Benito,Mandolin S. Ziadie,Karine Hovanes +12 more
TL;DR: SNP-based CMA can identify aneuploidy, polyploidsy, whole-genome homozygosity, segmental genomic imbalances, and maternal cell contamination, thus maximizing sensitivity and decreasing false-negative results.
Journal ArticleDOI
Molecular Testing for Cystic Fibrosis Carrier Status Practice Guidelines: Recommendations of the National Society of Genetic Counselors
Elinor Langfelder-Schwind,Barbara A. Karczeski,Michelle N. Strecker,Joy B Redman,Elaine A Sugarman,Christina Zaleski,Trisha Brown,Steven Keiles,Amy Powers,Sumheda Ghate,Rebecca J. Darrah +10 more
TL;DR: The goals of these recommendations are to provide updated information about the natural history, diagnosis, and treatment of CF and related conditions and Supplement genetic counselors’ knowledge and understanding of the available carrier screening and diagnostic testing options.
Journal ArticleDOI
Comprehensive genetic analysis of pregnancy loss by chromosomal microarrays: Outcomes, benefits, and challenges
Trilochan Sahoo,Natasa Dzidic,Michelle N. Strecker,Sara Commander,Mary K. Travis,Charles Doherty,R. Weslie Tyson,Arturo E. Mendoza,Mary D. Stephenson,Craig A. Dise,Carlos W. Benito,Mandolin S. Ziadie,Karine Hovanes +12 more
TL;DR: Evaluating the effectiveness and diagnostic capability of CMA in fresh and formalinfixed paraffin-embedded samples of products of conception (POCs) and determining the benefits of POC analysis by SNP-based CMA for chromosomal imbalances concluded that the high diagnostic sensitivity of SNP- based CMA enables the understanding of the causes of fetal loss and determination of recurrence risk, thus assisting with future family planning.